T1	CHEM 74 85	vatiquinona
T2	PROC 137 143	tratar
T3	DISO 147 167	ataxia de Friedreich
#1	AnnotatorNotes T3	C0016719; Friedreich Ataxia; Disease or Syndrome
T4	DISO 173 194	condición neurológica
T5	PROC 215 230	Estudio abierto
T6	Date 231 244	a largo plazo
T7	PROC 250 284	evaluar la seguridad y la eficacia
T8	CHEM 288 299	vatiquinona
T9	LIVB 303 312	pacientes
#2	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	DISO 317 337	ataxia de Friedreich
#3	AnnotatorNotes T10	C0016719; Friedreich Ataxia; Disease or Syndrome
T11	DISO 362 382	ataxia de Friedreich
#4	AnnotatorNotes T11	C0016719; Friedreich Ataxia; Disease or Syndrome
T12	DISO 390 438	enfermedad neurodegenerativa autosómica recesiva
T13	ANAT 468 484	sistema nervioso
#5	AnnotatorNotes T13	C0027763; Nervous system structure; Body System | C1269560; Entire nervous system; Body System
T14	ANAT 490 497	corazón
#6	AnnotatorNotes T14	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T15	DISO 523 543	Ataxia de Friedreich
#7	AnnotatorNotes T15	C0016719; Friedreich Ataxia; Disease or Syndrome
T16	LIVB 576 583	persona
#8	AnnotatorNotes T16	C0027361; Persons; Population Group
T17	PROC 594 608	consentimiento
T18	LIVB 630 638	Personas
#9	AnnotatorNotes T18	C0027361; Persons; Population Group
T19	DISO 643 645	AF
#10	AnnotatorNotes T19	C0015625; Fanconi Anemia; Disease or Syndrome | C0016719; Friedreich Ataxia; Disease or Syndrome
T20	PROC 668 683	estudio clínico
#11	AnnotatorNotes T20	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T21	Date 788 794	actual
T22	PROC 866 887	método anticonceptivo
#12	AnnotatorNotes T22	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T23	DEVI 905 914	implantes
#13	AnnotatorNotes T23	C0021102; Implants; Medical Device
T24	Route 916 927	inyectables
T25	DEVI 929 948	parche transdérmico
#14	AnnotatorNotes T25	C0991556; Transdermal System; Medical Device
T26	Form 929 935	parche
T27	Route 936 948	transdérmico
T28	Route 966 972	orales
T29	PROC 985 1003	métodos de barrera
#15	AnnotatorNotes T29	C0004764; Contraception, Barrier; Therapeutic or Preventive Procedure
T30	DEVI 1006 1032	dispositivos intrauterinos
#16	AnnotatorNotes T30	C0021900; Intrauterine Devices; Medical Device
T31	PROC 1077 1091	consentimiento
T32	Duration 1098 1105	30 días
T33	CHEM 1137 1159	medicamento en estudio
T34	PROC 1168 1174	visita
T35	LIVB 1207 1214	hombres
#17	AnnotatorNotes T35	C0025266; Male population group; Population Group | C0086418; Homo sapiens; Human
T36	Neg_cue 1237 1239	no
T37	PROC 1240 1251	donar semen
T38	Negated 1240 1251	donar semen
T39	Duration 1281 1297	al menos 30 días
T40	CHEM 1329 1340	medicamento
#18	AnnotatorNotes T40	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T41	PROC 1349 1355	visita
T42	Neg_cue 1407 1413	ningún
T43	PROC 1419 1440	método anticonceptivo
#19	AnnotatorNotes T43	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T44	Negated 1419 1440	método anticonceptivo
T45	PROC 1472 1495	método de doble barrera
T46	Date 1580 1586	actual
T47	PROC 1605 1627	estudio intervencional
T48	PHYS 1632 1640	Embarazo
#20	AnnotatorNotes T48	C0032961; Pregnancy; Organism Function
T49	PHYS 1643 1652	lactancia
#21	AnnotatorNotes T49	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T50	Date 12 16	2022
T51	PROC 44 131	Estudio para determinar si la vatiquinona, medicación del estudio, es segura y efectiva
T52	PROC 780 787	estudio
T53	LIVB 804 830	mujeres y hombres fértiles
T54	Route 905 914	implantes
T55	CHEM 950 983	anticonceptivos orales combinados
T56	PROC 1263 1270	estudio
T57	DEVI 1505 1533	preservativo con espermicida
T58	CHEM 87 109	medicación del estudio
T59	Quantifier_or_Qualifier 114 120	segura
T60	Quantifier_or_Qualifier 123 131	efectiva
T61	Observation 614 624	participar
T62	Observation 654 683	completado un estudio clínico
T63	Observation 845 855	dispuestos
T64	Quantifier_or_Qualifier 888 896	efectivo
T65	CONC 1120 1132	última dosis
T66	Quantifier_or_Qualifier 1175 1201	de finalización anticipada
T67	CONC 1312 1324	última dosis
T68	Quantifier_or_Qualifier 1356 1382	de finalización anticipada
T69	Observation 1566 1627	Participación actual en cualquier otro estudio intervencional
T70	Patient 303 312	pacientes
T71	Patient 576 583	persona
T72	Patient 630 638	Personas
T73	History_of 668 683	estudio clínico
T74	Patient 804 811	mujeres
T75	Patient 814 830	hombres fértiles
T76	Patient 1207 1214	hombres
